These restrictions on the BTNX NTS are highly appropriate, as we identified e.g. etodesnitazene to obtain the same in vitro potency and efficacy as fentanyl [7, 13] and as it could perhaps give PWUD a Wrong sense of protection. Also, the detectability of nitazene analogues in drug samples can be impacted by solubility difficulties, as highlighted b